Abstract-The hypothesis that ␣ 2 -antiplasmin (␣ 2 -AP), the main physiological plasmin inhibitor, plays a role in neointima formation was tested with use of a vascular injury model in wild-type (␣ 2 -AP ϩ/ϩ ) and ␣ 2 -AP-deficient (␣ 2 -AP Ϫ/Ϫ ) mice. The neointimal and medial areas were similar 1 to 3 weeks after electric injury of the femoral artery in ␣ 2 -AP ϩ/ϩ and ␣ 2 -AP Ϫ/Ϫ mice, resulting in comparable intima/media ratios (eg, 0.43Ϯ0.12 and 0.42Ϯ0.11 2 weeks after injury). Nuclear cell counts in cross-sectional areas of the intima of the injured region were also comparable in arteries from ␣ 2 -AP ϩ/ϩ and ␣ 2 -AP Ϫ/Ϫ mice (78Ϯ19 and 69Ϯ8). Fibrin deposition was not significantly different in arteries of both genotypes 1 day after injury, and no mural thrombosis was detected 1 week after injury. Fibrinolytic activity in femoral arterial sections, as monitored by fibrin zymography, was higher in ␣ 2 -AP Ϫ/Ϫ mice 1 week after injury (PϽ0.001) but was comparable in both genotypes 2 and 3 weeks after injury. Staining for elastin did not reveal significant degradation of the internal elastica lamina in either genotype. Immunocytochemical analysis revealed a comparable distribution pattern of ␣-actin-positive smooth muscle cells in both genotypes. These findings indicate that the endogenous fibrinolytic system of ␣ 2 -AP ϩ/ϩ mice is capable of preventing fibrin deposition after vascular injury and suggest that ␣ 2 -AP does not play a major role in smooth muscle cell migration and neointima formation in vivo. (Arterioscler
N eointima formation, a wound healing process in response to vascular injury, may contribute to luminal stenosis. 1 It involves migration of smooth muscle cells (SMCs) from the media across the internal elastic lamina underneath the endothelium and deposition of extracellular matrix. [2] [3] [4] Proteinases of the plasminogen/plasmin and matrix metalloproteinase systems play a role in SMC migration by degrading the extracellular matrix that prevents migration. [5] [6] [7] [8] [9] [10] A crucial role of the plasminogen/plasmin system was suggested by the observation that in vivo SMC migration in the rat was inhibited by the plasmin inhibitor tranexamic acid. 11 More direct evidence of a role of plasmin was provided by the findings that arterial neointima formation after vascular injury was significantly impaired in urokinase-deficient and plasminogen-deficient mice. 12, 13 The perivascular electric injury model used in these studies also causes development of transient mural thrombosis early after injury. 14 The contribution of thrombosis to the subsequent neointima formation, however, is unclear.
The plasminogen/plasmin (fibrinolytic) system contains a proenzyme, plasminogen, that is activated to the active enzyme plasmin by tissue-type (tPA) or urokinase-type (uPA) plasminogen activator. Inhibition occurs through neutralization of tPA or uPA by type 1 plasminogen activator inhibitor (PAI-1) or through inhibition of plasmin by ␣ 2 -antiplasmin (␣ 2 -AP). 15 Recently, mice were generated with inactivation of the ␣ 2 -antiplasmin gene, the main physiological plasmin inhibitor. 16 As expected, these animals displayed a higher endogenous fibrinolytic potential than wild-type littermates, as revealed by a higher spontaneous lysis rate of experimental pulmonary emboli and decreased fibrin deposition in the kidneys after endotoxin injection. 16 In the present study, these mice were used to study the role of plasmin inhibition by ␣ 2 -AP in thrombosis early after electric injury and the subsequent effect on neointima formation.
Methods

Animals
␣ 2 -AP-deficient (␣ 2 -AP Ϫ/Ϫ ) and wild-type (␣ 2 -AP ϩ/ϩ ) mice (overall 50% C57/BL6 to 50% 129SVj genetic background) were obtained by intercrossing germline offspring from ␣ 2 -AP chimeras mated with wild-type C57/BL6 females without further backcrossing into the C57/BL6 or 129SVj background, and their genotypes were determined as described elsewhere. 16 Mice were kept in microisolation cages on a 12-hour-day/12-hour-night cycle and fed regular chow. Animals were anesthetized by intraperitoneal injection of 60 mg/kg Nembutal (Abbott Laboratories), and all experiments were performed in accordance with the guiding principles of the American Physiological Society and the International Society on Thrombosis and Haemostasis. 17 Adult mice 9 to 12 weeks old (males and females) were used. Mean body weight (ϮSEM) was 23Ϯ0.64 g for ␣ 2 -AP ϩ/ϩ mice (nϭ 28) and 23Ϯ0.65 g for ␣ 2 -AP Ϫ/Ϫ mice (nϭ 30). t tests were used for statistical analysis.
Vascular Injury Model
Perivascular electric injury to the femoral artery was induced essentially as described elsewhere. 14 In brief, arteries were exposed by blunt-end dissection and injured by electric current at distances of 1 mm over a total length of 2 or 3 mm. Control arteries were removed from noninjured mice, and injured arteries were collected 1 to 3 weeks after injury. Vessel segments were fixed in 1% paraformaldehyde or directly embedded in ornithine carbamyl transferase (Tissue-Tek), snap-frozen in precooled 2-methylbutane, and stored at Ϫ80°C. In addition, some animals were killed 1 day after injury and immediately perfused for 15 to 30 minutes with saline; arteries were removed and postfixed in paraffin. Seven-micron-thick sections were made throughout the whole arteries for histological and immunocytochemical studies. Blood was collected on 0.01 mol/L citrate, and platelet-poor plasma was prepared by centrifugation at 4000g for 5 minutes. Longitudinally alongside the artery, different positions corresponding to noninjured sections (positions 1 and 5), to borders of the injury (positions 2 and 4), and to the center of the injury (position 3) were identified (Figure, inset).
Histological and Immunocytochemical Studies
Morphometric measurements of cross-sectional areas were made and cell counts were performed in a blinded manner on fixed transverse arterial sections (stained with hematoxylin and eosin) using a computer-assisted image analysis system as described elsewhere. 14 Measurements were made at equally spaced positions (140 m apart) along the artery. Areas in the injured region of the artery (positions 2 to 4) were then averaged for each artery. Data are the meanϮSEM of these average values obtained for all arteries analyzed in each group.
For immunostaining of SMCs, biotinylated mouse anti-human smooth muscle ␣-actin (clone A14, Sigma Chemical Co) was used as primary antibody in combination with the Vectastain system (ABC Elite kit, Vector Laboratories Inc). Immunostaining for fibrin and fibrinogen was performed by incubating the sections with goat antiserum against murine fibrin (Nordic) in 0.01 mol/L Tris-HCl, pH 7.6, containing 0.9% NaCl and 0.1% Triton X-100 for 3 hours at room temperature. After rinsing, sections were incubated consecutively for 60 minutes with biotinylated rabbit anti-goat immunoglobulin G (IgG; Dako) and with peroxidase-labeled avidin-biotin complex (Dako). Peroxidase activity was developed by incubating sections in 0.05 mol/L Tris-HCl buffer, pH 7.0, containing 0.06% 3,3Ј-diaminobenzidine and 0.01% H 2 O 2 , followed by counterstaining with Harris' hematoxylin. Staining specificity was confirmed by omission of the primary antibody or by replacement of the antibody with equivalent amounts of isotype-matched nonimmune IgG or serum. Staining for elastin was performed with use of Verhoeff's and von Gieson's reagents.
Protein Assays and Zymographic Analysis
For extraction, femoral arteries dissected free of tissue were pulverized under liquid nitrogen and extracted for 1 hour at 4°C with 60 L of 10 mmol/L sodium phosphate buffer, pH 7.2, containing 150 mmol/L NaCl, 1% Triton X-100, 0.1% SDS, 0.5% sodium deoxycholate, and 0.2% sodium azide. After extensive vortexing and centrifugation at 13 000 rpm for 5 minutes, the protein concentration of the supernatants was determined (BCA protein assay, Pierce).
For zymographic analysis of plasminogen activator activity (tPA and uPA), arterial extracts were electrophoresed on a 12.5% acrylamide gel cast with 1% nonfat dry milk and 5 g/mL human plasminogen under nonreducing conditions. 18 Lysis of the substrate gel (area by intensity) was measured using Quantimed 600 image analysis software (Leica) and expressed in arbitrary units (AU) of lysis obtained per milligram of protein in the extract.
Fibrinolytic activity was monitored by fibrin overlay on 7-m cryostat sections (nonfixed) of arteries at 37°C for 2 hours. The lysis area (mm 2 ) was normalized to the total area of the section. ␣ 2 -AP and plasminogen antigen levels were measured by ELISA using polyclonal antibodies against the purified murine proteins raised in rabbits. 16 Plasmin-␣ 2 -AP complexes in plasma were measured using microtiter plates coated with polyclonal rabbit antimurine ␣ 2 -AP antibodies; after incubation of diluted plasma samples, bound complex was detected with HRP-conjugated polyclonal rabbit anti-murine plasminogen antibodies. For calibration, murine plasma 
Results
Histological and Immunocytochemical Studies
Hematoxylin and eosin staining of femoral arterial sections taken from noninjured arteries (control animals) showed comparable pictures for ␣ 2 -AP ϩ/ϩ and ␣ 2 -AP Ϫ/Ϫ mice; the adventitial and medial areas were comparable, and no significant neointima was detectable (Table 1 and Figure) . Nuclear cell counts in the media were comparable for both genotypes (Table 2) , as were counts for intimal (mainly endothelial) cells (19Ϯ2 in both genotypes).
Staining of sections obtained 1 to 3 weeks after injury at equally spaced locations (positions 2 to 4) throughout the damaged area showed the formation of a neointima in both ␣ 2 -AP ϩ/ϩ and ␣ 2 -AP Ϫ/Ϫ mice (Figure) . Overall, the intimal and medial areas were comparable, resulting in intima/media ratios that were not significantly different between both genotypes. However, 1 week after injury the intimal area and intima/media ratio appeared to be higher in ␣ 2 -AP ϩ/ϩ mice (Table 1) . Nuclear cell counts revealed a comparable cell population in media of normal sections (positions 1 and 5) of injured arteries (data not shown) and in control noninjured arteries (cf above). In the injured area (positions 2 to 4), cell counts were overall comparable over time in the media and intima of both genotypes (Table 2) .
Immunostaining for ␣-actin showed a similar picture for uninjured control arteries of ␣ 2 -AP ϩ/ϩ and ␣ 2 -AP Ϫ/Ϫ mice, with 2 or 3 layers of ␣-actin-immunoreactive cells in the media but none in the intima or adventitia (Figure) . One week after injury, virtually no ␣-actin-positive cells were detected in the intima of both genotypes, whereas they represented Ͻ20% of the cell population in the media in both genotypes (not shown). Two weeks after injury, ␣-actin-positive SMCs in the intima of both genotypes were more abundant at the borders of the injury than in the center, whereas at 3 weeks after injury, Ն70% of cells in the injured area were ␣-actinpositive ( Figure) . Staining for elastin did not reveal significant degradation of the internal elastica lamina in either genotype.
In separate experiments, femoral arteries were removed 1 day after electric injury and used for immunostaining with an antiserum against murine fibrin and fibrinogen. No fibrin was detected in sections of noninjured control arteries of ␣ 2 -AP ϩ/ϩ or ␣ 2 -AP Ϫ/Ϫ mice (nϭ4 each; not shown). One day after injury, no intravascular thrombosis in the lumen was observed in either genotype, whereas weak positive immunostaining for fibrin was observed in the adventitia of the damaged area in 4 of 4 ␣ 2 -AP ϩ/ϩ mice and 2 of 3 ␣ 2 -AP Ϫ/Ϫ mice (not shown). Plasma levels of plasmin-␣ 2 -AP complex in ␣ 2 -AP ϩ/ϩ mice were 1300Ϯ280 ng/mL in control animals (nϭ 8) and 1500Ϯ240 ng/mL in injured animals 1 day after injury (meanϮSEM, nϭ 6).
Protein Assays and Zymographic Analysis
In situ zymographic analysis was performed by fibrin overlay of arterial sections. This assay detects primarily tPA activity, as shown by the finding that lysis of the fibrin gel was virtually abolished on addition of anti-tPA antibodies (final concentration 200 g/mL gel) but was not significantly affected by anti-uPA antibodies (not shown). When the fibrinolytic activity (lysis zone) was normalized to the section area, fibrinolytic activities in control arteries of ␣ 2 -AP Ϫ/Ϫ mice were somewhat, but not significantly (Pϭ0.11), higher than those in ␣ 2 -AP ϩ/ϩ mice (Table 3) . One week after vascular injury, activity was significantly higher in ␣ 2 -AP Ϫ/Ϫ arteries, whereas no significant difference was observed 2 to 3 weeks after injury.
Determination of fibrinolytic parameters in femoral arterial extracts revealed somewhat higher tPA activity in ␣ 2 -AP Ϫ/Ϫ arteries 1 week after injury and somewhat higher uPA activity in control arteries of ␣ 2 -AP Ϫ/Ϫ mice (Table 4) . At other time points, both activities were comparable for both genotypes. Plasminogen antigen levels were also comparable. ␣ 2 -AP antigen levels were enhanced 1 and 2 weeks after injury compared with controls (Pϭ0.07).
Discussion
Neointima formation plays a role in the pathogenesis of atherosclerosis, restenosis after angioplasty, and late vein graft failure. 19 It involves degradation of extracellular matrix by proteinases of the plasminogen/plasmin or matrix metalloproteinase system, with migration of SMCs from the media to the intima. 2, 3 We used a perivascular electric injury model 14 in ␣ 2 -AP ϩ/ϩ and ␣ 2 -AP Ϫ/Ϫ mice to study the role of ␣ 2 -AP, the main physiological plasmin inhibitor, in neointima formation. In this model, wound healing is initiated from the adjacent uninjured borders, progresses into the necrotic center, and is associated with migration of SMCs. One to 2 weeks after injury, the intimal cell population is heterogeneous, consisting not only of ␣-actin-positive SMCs but also of leukocytes and occasionally macrophages. [12] [13] [14] As in other models in the rat and pig, mural thrombosis early after injury is frequently observed. 14, 20, 21 Mural thrombosis is also frequently observed after vascular reconstruction in humans, and it has been suggested that colonization of such thrombi may contribute to the development of intimal lesions. 1,2,22-24 Therefore, we investigated a potential relation between early thrombosis and subsequent neointima formation. However, 1 day after vascular injury, fibrin deposition did not appear to be significantly different between femoral arteries of ␣ 2 -AP ϩ/ϩ and ␣ 2 -AP Ϫ/Ϫ mice and mural thrombosis was not observed. One week after injury, all thrombi were cleared in both genotypes. This finding contrasts with results of previous studies using this model, which reported mural thrombosis occluding the lumen by Ͻ25% in about one quarter of wild-type mice. 12, 13 It is not clear whether this difference is due to a difference in genetic background of the mice (overall 75% C57/BL6 and 25% 129SVPas versus overall 50% C57/BL6 and 50% 129SVj in this study). In any case, in this model mural thrombi appear to be lysed before accumulation of SMCs and neointima formation occur. 14 No significant difference in neointima formation was observed in both genotypes 1 to 3 weeks after injury. This suggests that neointima formation after electric injury does not develop from colonization of thrombi. This observation is in agreement with general clinical observations in patients after vascular interventions, in whom thrombi can be lysed or limited by use of thrombolytic agents without affecting the occurrence of restenosis. In contrast, efficient antithrombotic strategies (eg, glycoprotein IIb/IIIa antagonists) appear to be effective in limiting restenosis. 25, 26 The similar neointima formation in ␣ 2 -AP ϩ/ϩ and ␣ 2 -AP Ϫ/Ϫ mice also indicates that the physiological plasmin inhibitor does not play a major role. This is somewhat surprising in view of previous studies showing impaired neointima formation in uPA and in plasminogen-deficient mice, 12,13 thus suggesting a key role of plasmin. The aim of this study, however, was not to study the role of plasmin directly but to evaluate the role of ␣ 2 -AP, 1 (albeit the physiologically most relevant) of the plasmin inhibitors in plasma. In contrast to the present findings on the role of ␣ 2 -AP, we previously showed that PAI-1, the main physiological plasminogen activator inhibitor, plays an inhibitory role in vascular wound healing and neointima formation after injury. PAI-1 apparently functions by affecting SMC migration, most likely as a result of inhibition of uPA-mediated proteolysis. 27 It was suggested previously that other serine proteinase inhibitors in the murine system may compensate for the lack of ␣ 2 -AP. This may explain the absence of a bleeding Data represent the ratio of the lysis area to the total section area and are meanϮSEM of the number of determinations (indicated in parentheses). Sections were obtained from areas 2 to 4 of the injured and from control arteries. *PϽ0.001 vs ␣ 2 -AP ϩ/ϩ . phenotype in ␣ 2 -AP Ϫ/Ϫ mice 16 in contrast to homozygous ␣ 2 -AP-deficient patients. However, in injured sections of wild-type mice, significant plasmin activity can be generated locally at the sites of injury, as shown by fibrin zymography, which revealed significant fibrinolytic activity. This was higher in arteries from ␣ 2 -AP Ϫ/Ϫ mice 1 week after injury (Table 3) , consistent with higher tPA activity levels measured by casein zymography with arterial extracts (Table 4) . However, 2 to 3 weeks after injury there were no significant differences. Expression of ␣ 2 -AP after vascular injury in wild-type mice is confirmed by the ␣ 2 -AP levels in femoral arterial extracts. Activation of the fibrinolytic system 1 day after vascular injury, however, seems to be limited, as evidenced by unaltered levels of plasma plasmin-␣ 2 -AP complex in comparison with control animals.
Together these findings indicate that the endogenous fibrinolytic system of ␣ 2 -AP ϩ/ϩ mice is capable of preventing mural thrombosis after vascular injury and suggest that ␣ 2 -AP does not play a major role in SMC migration and neointima formation in vivo.
